LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences

14.11.24 15:00 Uhr

Werte in diesem Artikel
Aktien

45,60 EUR 0,00 EUR 0,00%

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present a general business update during fireside chats at the three following healthcare conferences in New York in November and December:

  • Stifel Healthcare Conference 2024 on Tuesday, November 19 from 11:30 a.m. - 12:00 p.m. Eastern Time,
  • 6th Annual Wolfe Research Healthcare Conference on Wednesday, November 20 from 1:20 - 1:50 p.m. Eastern Time, and
  • Piper Sandler Healthcare Conference on Tuesday, December 3 from 10:00 - 10:25 a.m. Eastern Time.

All three fireside chats will stream live with recordings available afterward. To access event links, visit the Livanova website at www.livanova.com/events.

About LivaNova

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in London, LivaNova employs approximately 2,900 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains "forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.

Ausgewählte Hebelprodukte auf Livanova

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Livanova

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Livanova PLC

Analysen zu Livanova PLC

DatumRatingAnalyst
28.02.2019Livanova BuyNeedham & Company, LLC
02.08.2018Livanova BuyNeedham & Company, LLC
08.06.2018Livanova BuyStifel, Nicolaus & Co., Inc.
31.05.2018Livanova BuyNeedham & Company, LLC
28.02.2018Livanova BuyNeedham & Company, LLC
DatumRatingAnalyst
28.02.2019Livanova BuyNeedham & Company, LLC
02.08.2018Livanova BuyNeedham & Company, LLC
08.06.2018Livanova BuyStifel, Nicolaus & Co., Inc.
31.05.2018Livanova BuyNeedham & Company, LLC
28.02.2018Livanova BuyNeedham & Company, LLC
DatumRatingAnalyst
23.08.2017Livanova HoldNeedham & Company, LLC
03.11.2016Livanova HoldCanaccord Adams
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Livanova PLC nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"